New GHX Supply Chain Product Data Report Reveals Continued Growth in Key Healthcare Segments Through Mid-Year 2016

Findings reveal Alternate Site Locations continue to expand in healthcare; Wound Staples & Sutures sales rebounding; and Immunology Reagents/Supplies sales continue to surge
Louisville, CO - Wednesday, September 14, 2016 -

Global Healthcare Exchange, LLC (GHX) released second quarter data and trends for distributed sales in both Medical-Surgical (med-surg) and Clinical Laboratory (clin-lab) product segments in healthcare. The new GHX Market Intelligence “By the Numbers” quarterly research revealed that the med-surg segment grew 6.3percent in the second quarter to $9.1B in volume and 2.3 percent growth compared to second quarter 2015 ($8.6B). Clin-lab decreased 5.1 percent to $1.9B in the second quarter compared to results in second quarter 2015 ($1.8B).

The newly released GHX Market Intelligence quarterly research is based on data from the top 20 U.S. healthcare distributors, representing 75 percent of all distributed healthcare sales in the United States. This represents $40B+ invoice dollars and 100M invoice lines of distributed sales for med-surg and clin-lab products and supplies annually. 

“GHX Market Intelligence data confirms that the healthcare market continues to grow,” said Paul Frank, manager, Product Management Business Intelligence, GHX. “What our most recent data shows is that healthcare providers continue to respond to rapidly changing market conditions and financial pressures, especially in regard to growth in Alternate Site markets within med-surg. In Q2, Alternate Site showed a solid year over year growth of 6 percent in med-surg and 7 percent in clin-lab segments.”

The complete second quarter 2016 Clinical Laboratory Segment and Medical-Surgical Segment reports are available at GHX Market Intelligence. Highlights from the Q2 reports include:

Q2 2016 By the Numbers: Medical-Surgical Segment

Medical-Surgical Volume: (dollar volume by market segment)

  • The dollar volume of the med-surg segment totaled $9.1B in Q2 2016
  • Parenteral was the largest major segment in med-surg at $720 M or 8.1 percent of total med-surg

Total Medical-Surgical Market Quarterly

  • Med-surg market segments as a whole experienced a 2.3 percent current quarter over quarter increase, growing from $8.9B in Q1 2016 to $9.1B in Q2 2016
  • Hospital segment experienced quarter over quarter percent increase of 2.1 percent growing from $5.9B in Q1 2016 to $6B in Q2 2016
  • Alternate Site markets experienced quarter over quarter increases of 2.7 percent from Q1 2016 to Q2 2016
  • Within Alternate Site, Treatment Centers experienced the largest percent increase of 6.3 percent growing from $361M in Q1 2016 to $384M in Q2 2016

Q2 2016 By the Numbers: Clinical Laboratory Segment

Market Segment Leaders: (dollar volume by market segment)

  • Point-of-Care Testing Reagents/Supplies was the largest major segment in Q2 at $941M or48.9 percent of total clin-lab
  • Home Healthcare is the largest contributor at $724M or 37.6 percent of the total clin-lab volume
  • Hospital was the second largest contributor in volume at $613.1M or 31.9 percent

Total Clinical Laboratory Market Quarterly:

  • Clin-lab markets as a whole experienced a 5 percent current quarter over quarter decrease, dropping from $2.02B in Q1 2016 to $1.92B in Q2 2016
  • Alternate Site segments also experienced quarter over quarter percent decrease of 5.3 percent decline from $1.38B in Q1 2016 to $1.31B in Q2 2016
  • Long Term Care was the only dollar increase of $27M and representing 2.3% growth

Report Methodology

GHX Market Intelligence methodology and processes have been in existence for nearly 20 years, being refined and optimized to be the most accurate and complete source for market size and market share reporting for Clinical Laboratory and Medical-Surgical. Each month, GHX receives data from the top 20 U.S. healthcare distributors. The distributed sales information then goes through a rigorous process where the data is standardized, normalized and classified, using GHX proprietary algorithms, nomenclature and credentialed professionals. 

About GHX

Global Healthcare Exchange, LLC (GHX) drives costs out of healthcare with cloud-based supply chain management technology and services in order to help enable better patient care and savings by maximizing automation, efficiency, and accuracy of business processes. GHX offers healthcare providers and suppliers an open and neutral electronic trading exchange that delivers procurement and accounts payable automation, contract and inventory management, vendor credentialing and management, business intelligence, payment management, and other supply chain-related tools and services. For more information, visit and The Healthcare Hub.